Natural Drugs as a Treatment Strategy for Cardiovascular Disease through the Regulation of Oxidative Stress.
Xing ChangTian ZhangWenjin ZhangZhenyu ZhaoJiahui SunPublished in: Oxidative medicine and cellular longevity (2020)
Oxidative stress (OS) refers to the physiological imbalance between oxidative and antioxidative processes leading to increased oxidation, which then results in the inflammatory infiltration of neutrophils, increased protease secretion, and the production of a large number of oxidative intermediates. Oxidative stress is considered an important factor in the pathogenesis of cardiovascular disease (CVD). At present, active components of Chinese herbal medicines (CHMs) have been widely used for the treatment of CVD, including coronary heart disease and hypertension. Since the discovery of artemisinin for the treatment of malaria by Nobel laureate Youyou Tu, the therapeutic effects of active components of CHM on various diseases have been widely investigated by the medical community. It has been found that various active CHM components can regulate oxidative stress and the circulatory system, including ginsenoside, astragaloside, and resveratrol. This paper reviews advances in the use of active CHM components that modulate oxidative stress, suggesting potential drugs for the treatment of various CVDs.
Keyphrases
- oxidative stress
- cardiovascular disease
- dna damage
- healthcare
- type diabetes
- randomized controlled trial
- diabetic rats
- nitric oxide
- small molecule
- induced apoptosis
- metabolic syndrome
- signaling pathway
- combination therapy
- risk assessment
- replacement therapy
- mass spectrometry
- endoplasmic reticulum stress
- single molecule
- cardiovascular events
- anti inflammatory
- plasmodium falciparum
- meta analyses